首页> 外文期刊>Journal of Translational Medicine >Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease
【24h】

Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease

机译:p53 / miR-155-5p / sirt1环在糖尿病肾病肾小管损伤中的作用

获取原文
           

摘要

Diabetic kidney disease is a renal microvascular disease caused by diabetes, known as one of the most serious and lethal complications of diabetes. Early renal hypertrophy is the main pathological feature, which gradually leads to the deposition of glomerular extracellular matrix and tubulointerstitial fibrosis, eventually developing irreversible structural damage to the kidneys. Autophagy is a cell self-homeostatic mechanism that is activated under stress conditions and may serve as a protective response to the survival of renal fibrogenic cells. MicroRNA (miRNA) network may be involved in the regulation of fibrosis. The purpose of this study is to assess how miRNAs regulate diabetic kidney disease and autophagy and fibrosis in renal proximal tubular cells under high glucose conditions. Human renal proximal tubular (HK-2) cells were exposed to high glucose in vitro. Bioinformatic analysis was used to select the candidate gene for potential target regulation of miR-155, Sirt1. ATG5, ATG7 is the key to autophagosome formation, regulated by Sirt1. p53 regulates miR-155 expression as a transcription factor. MiR-155 overexpression and inhibition were achieved by transfection of miR-155 mimic and inhibit to evaluate its effect on Sirt1 and autophagy and fibrosis markers. Dual luciferase reporter assays were used to confirm the direct interaction of Sirt1 with miR-155. Overexpression and inhibition of Sirt1 gene were achieved by transfection of Sirt1 plasmid and Sirt1 si to observe its effect on P53. Chip assay experiments confirmed the direct regulation of P53 on miR-155. Under high glucose conditions, miR-155 was detected in HK-2 cells in concentration gradient, increased expression of p53 and down-regulated expression of sirt1 and autophagy-associated proteins LC3II, ATG5 and ATG7. Dual luciferase reporter assays indicate that miR-155 can target its binding to the Sirt1 3′UTR region to reduce its expression. Under high glucose conditions, over expression of miR-155 decreased the expression of LC3-II and ATG5 in HK-2 cells, while inhibition of miR-155 reversed this effect. Using chip assay testing in HK-2 cells, we demonstrated that p53 binds directly to miR-155. The signaling axis of p53, miR-155-5p, and sirt1 in autophagic process might be a critical adapting mechanism for diabetic kidney injury.
机译:糖尿病性肾脏疾病是由糖尿病引起的肾脏微血管疾病,被称为糖尿病最严重和致命的并发症之一。早期肾脏肥大是主要的病理特征,逐渐导致肾小球细胞外基质的沉积和肾小管间质纤维化,最终对肾脏产生不可逆的结构损伤。自噬是一种细胞自我平衡机制,可在压力条件下被激活,并可以作为对肾纤维化细胞存活的保护性反应。 MicroRNA(miRNA)网络可能参与纤维化的调节。这项研究的目的是评估在高葡萄糖条件下,miRNA如何调节糖尿病性肾脏疾病以及肾脏近端肾小管细胞的自噬和纤维化。人肾近端肾小管(HK-2)细胞在体外暴露于高葡萄糖。生物信息学分析用于选择可能的miR-155,Sirt1靶标调控基因。 ATG5,ATG7是由Sirt1调控的自噬体形成的关键。 p53调节miR-155表达作为转录因子。通过转染miR-155模拟物并进行抑制来评估其对Sirt1和自噬和纤维化标记物的作用,从而实现了MiR-155的过表达和抑制。使用双重荧光素酶报告基因测定法来确认Sirt1与miR-155的直接相互作用。通过转染Sirt1质粒和Sirt1 si来实现Sirt1基因的过表达和抑制,以观察其对P53的作用。芯片分析实验证实了miR-155上P53的直接调节。在高葡萄糖条件下,在HK-2细胞中以浓度梯度检测到miR-155,p53表达增加,sirt1和自噬相关蛋白LC3II,ATG5和ATG7的表达下调。双重荧光素酶报告基因检测表明,miR-155可以靶向其与Sirt1 3'UTR区的结合,从而降低其表达。在高葡萄糖条件下,miR-155的过度表达会降低HK-2细胞中LC3-II和ATG5的表达,而对miR-155的抑制则会逆转这种作用。使用HK-2细胞中的芯片分析测试,我们证明了p53直接与miR-155结合。自噬过程中p53,miR-155-5p和sirt1的信号传导轴可能是糖尿病肾损伤的关键适应机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号